Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue

Out of the tested candidates, hyaluronidase showed the best potential to facilitate viral spread in tumor tissue and transduction of tumor cells. Therefore, hyaluronidase may be used as vehicle to improve clinical efficacy of oncolytic virotherapies.

Authors

Institutions

Publication Details

Journal
Upsala Journal of Medical Sciences
Published
2025-01-27
DOI
https://doi.org/10.48101/ujms.v130.11217
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue

Sofie Ingvast, Di Yu, Erik Yngve, Olle Korsgren
Upsala Journal of Medical Sciences
Virus-based gene therapy research
article

Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue

Sofie Ingvast, Di Yu, Erik Yngve, Olle Korsgren
article en

Abstract

Out of the tested candidates, hyaluronidase showed the best potential to facilitate viral spread in tumor tissue and transduction of tumor cells. Therefore, hyaluronidase may be used as vehicle to improve clinical efficacy of oncolytic virotherapies.

Upsala Journal of Medical SciencesVol. 130
Uppsala University (SE)
Sjöbergstiftelsen, Cancerfonden, Medical Research Council
Openalex Percentile: Top 98%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.